Evidence map›Paper›PMID 32150541›Full record

ArticlePLoS genetics2020

A putative silencer variant in a spontaneous canine model of retinitis pigmentosa.

Maria Kaukonen, Ileana B Quintero, Abdul Kadir Mukarram, Marjo K Hytönen, Saila Holopainen, Kaisa Wickström, Kaisa Kyöstilä, Meharji Arumilli, Sari Jalomäki, Carsten O Daub and 3 more

Open access · goldAbstract read
In one paragraph

Article in PLoS genetics, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
0.8field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Whole exome sequencing as a screening tool in dogs: A pilot study.Computational and structural biotechnology journal · 2025
    Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Formal commentary.PLoS genetics · 2020
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors at 3 institutions in 2 countries.

Maria KaukonenDepartment of Veterinary Biosciences, University of Helsinki, Helsinki, Finland.ORCID 0000-0002-2146-4694
Ileana B QuinteroDepartment of Veterinary Biosciences, University of Helsinki, Helsinki, Finland.
Abdul Kadir MukarramDepartment of Biosciences and Nutrition, Karolinska Institutet, Huddinge, Sweden.ORCID 0000-0002-9726-0399
Marjo K HytönenDepartment of Veterinary Biosciences, University of Helsinki, Helsinki, Finland.ORCID 0000-0003-1976-5874
Saila HolopainenDepartment of Veterinary Biosciences, University of Helsinki, Helsinki, Finland.ORCID 0000-0002-2448-7672
Kaisa WickströmVeterinary Clinic Kamu, Oulu, Finland.ORCID 0000-0003-4168-9951
Kaisa KyöstiläDepartment of Veterinary Biosciences, University of Helsinki, Helsinki, Finland.
Meharji ArumilliDepartment of Veterinary Biosciences, University of Helsinki, Helsinki, Finland.ORCID 0000-0003-4072-0996
Sari JalomäkiVeterinary Clinic Malmin Eläinklinikka Apex, Helsinki, Finland.ORCID 0000-0003-0755-0948
Carsten O DaubDepartment of Biosciences and Nutrition, Karolinska Institutet, Huddinge, Sweden.ORCID 0000-0002-3295-8729
Juha KereFolkhälsan Research Center, Helsinki, Finland.
Hannes LohiDepartment of Veterinary Biosciences, University of Helsinki, Helsinki, Finland.ORCID 0000-0003-1087-5532
DoGA Consortium
University of Helsinki · FIKarolinska Institutet · SEScience for Life Laboratory · SE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Retinitis pigmentosa (RP) is the leading cause of blindness with nearly two million people affected worldwide. Many genes have been implicated in RP, yet in 30-80% of the RP patients the genetic cause remains unknown. A similar phenotype, progressive retinal atrophy (PRA), affects many dog breeds including the Miniature Schnauzer. We performed clinical, genetic and functional experiments to identify the genetic cause of PRA in the breed. The age of onset and pattern of disease progression suggested that at least two forms of PRA, types 1 and 2 respectively, affect the breed, which was confirmed by genome-wide association study that implicated two distinct genomic loci in chromosomes 15 and X, respectively. Whole-genome sequencing revealed a fully segregating recessive regulatory variant in type 1 PRA. The associated variant has a very recent origin based on haplotype analysis and lies within a regulatory site with the predicted binding site of HAND1::TCF3 transcription factor complex. Luciferase assays suggested that mutated regulatory sequence increases expression. Case-control retinal expression comparison of six best HAND1::TCF3 target genes were analyzed with quantitative reverse-transcriptase PCR assay and indicated overexpression of EDN2 and COL9A2 in the affected retina. Defects in both EDN2 and COL9A2 have been previously associated with retinal degeneration. In summary, our study describes two genetically different forms of PRA and identifies a fully penetrant variant in type 1 form with a possible regulatory effect. This would be among the first reports of a regulatory variant in retinal degeneration in any species, and establishes a new spontaneous dog model to improve our understanding of retinal biology and gene regulation while the affected breed will benefit from a reliable genetic testing.

Indexed as

AnimalsCase-Control StudiesCollagen Type IXDog DiseasesDogsEndothelin-2FemaleFrameshift MutationGenome-Wide Association StudyHaplotypesMaleModels, AnimalMutationPedigreePhenotypeRetinaCollagen Type IXEndothelin-2

Identifiers

PMID32150541
PMCPMC7082071
OpenAlexW3010878100

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.